Viral and non-viral approaches for transient delivery of mRNA and proteins.
about
Cell-type specific penetrating peptides: therapeutic promises and challengesConcise review: Generation of neurons from somatic cells of healthy individuals and neurological patients through induced pluripotency or direct conversionInduced pluripotent stem cell-derived neural stem cell therapies for spinal cord injuryCarbon-dot-based two-photon visible nanocarriers for safe and highly efficient delivery of siRNA and DNA.Influence of untranslated regions on retroviral mRNA transfer and expressionInhibition of Xenograft tumor growth by gold nanoparticle-DNA oligonucleotide conjugates-assisted delivery of BAX mRNAEfficient transient genetic manipulation in vitro and in vivo by prototype foamy virus-mediated nonviral RNA transferCell-penetrating peptides: Possible transduction mechanisms and therapeutic applications.Transfection of pseudouridine-modified mRNA encoding CPD-photolyase leads to repair of DNA damage in human keratinocytes: a new approach with future therapeutic potentialNucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines.Nanotechnology-based approaches for the development of diagnostics, therapeutics, and vaccines.RNA-based drugs and vaccines.The application of virus-like particles as vaccines and biological vehicles.Viral and Synthetic RNA Vector Technologies and Applications.Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems.Biomimetic antigenic nanoparticles elicit controlled protective immune response to influenza.Deciphering the impact of parameters influencing transgene expression kinetics after repeated cell transduction with integration-deficient retroviral vectors.
P2860
Q26800103-79B15F2B-A696-4EB0-905A-C7194EE2D816Q27004350-F576B403-1681-4CDE-9B93-D9E05BA24B6EQ28081025-0837802D-0F64-40BE-9C70-75319ABB676FQ34052937-1F6BCD8A-F51A-4230-8846-C69E5C4D4989Q34668961-EEA1FD30-3978-4197-BC72-DDCFED8B6690Q35000872-7EE66D0C-ABF1-4B03-B0F3-722CDE4F2F6AQ35618845-3EF108BB-D0FB-4125-8063-CAF0D9B22519Q36824518-5F300B6C-FA26-4C8E-BBD0-91DBB496F6F8Q37466804-5CC9B8D0-5DD4-404C-999D-E419253FF0B1Q38199151-6B3AFF27-B5A8-4834-85E0-A6C45C921BA8Q38220897-95BFC01A-F2D3-4C9E-A9D2-4773D8759137Q38249163-BCA20831-EFE4-4555-BF3D-E3FB3F4F51C8Q38603912-1D2AA412-9685-4251-8881-2B6FBF030FACQ38885624-8F6BC68A-9119-402E-AF9E-DBF0BD745E2AQ39091854-DBF20720-C004-4A58-80DA-E518AC42508BQ41942589-6F1B7FDF-EE9F-480A-BC18-850B049C989EQ42158445-BB58AFF7-B6A1-40BE-B50D-1487F870ECF9
P2860
Viral and non-viral approaches for transient delivery of mRNA and proteins.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Viral and non-viral approaches for transient delivery of mRNA and proteins.
@en
Viral and non-viral approaches for transient delivery of mRNA and proteins.
@nl
type
label
Viral and non-viral approaches for transient delivery of mRNA and proteins.
@en
Viral and non-viral approaches for transient delivery of mRNA and proteins.
@nl
prefLabel
Viral and non-viral approaches for transient delivery of mRNA and proteins.
@en
Viral and non-viral approaches for transient delivery of mRNA and proteins.
@nl
P2093
P1433
P1476
Viral and non-viral approaches for transient delivery of mRNA and proteins.
@en
P2093
Christopher Baum
Juliane W Schott
Melanie Galla
Tamaryin Godinho
P304
P356
10.2174/156652311797415872
P407
P577
2011-10-01T00:00:00Z